2004.-Alternative splicing is one of the major sources of the large transcriptional diversity found in human cells. Splicing variants have been shown to be associated with features like spreading and progression in several human tumors. Therefore, such variants may be of great importance as both diagnostic and therapeutic tools. Here, by using a set of criteria regarding the expression pattern of splicing variants and statistical analyses, we were able to screen the genome for exons overexpressed in tumors of specific tissues. However, as in other analyses attempting to identify tumor-associated variants, our list of candidates was seriously inflated with cases of genes differentially expressed in tumors. To exclude these cases and increase the probability of finding bona fide regulated splicing variants, we performed a serial analysis of gene expression (SAGE), excluding those genes that were shown to be upregulated in tumors. This allowed us to predict the overexpression of single exons in specific tumors. Our final group of candidates includes 1,386 exons belonging to 638 genes. Experimental validation of a few candidates in normal tissue, tumor cell lines, and patient samples suggests that most of these candidates are indeed tumor-associated exons. Further functional classification of our candidate genes shows that our final list is slightly inflated with cancer-related genes. alternative splicing; tumor; transcriptome; serial analysis of gene expression ALTERNATIVE SPLICING is one of the main sources of the variability found in the human transcriptome (3). There are four different types of alternative splicing: exon skipping/usage, alternative usage of a donor site, alternative usage of an acceptor site, and intron retention (20). Several bioinformatics analyses have indicated that at least one-half of all human genes undergo alternative splicing (7,11,17,22,23). In roughly 80% of these cases, alternative splicing invokes changes in the coding region (CDS) of genes, resulting in structural changes of the respective protein product (14, 23).The biological impact of alternative splicing is perceptible, for example, in Drosophila, in which sex determination is triggered by alternative splicing of a master gene (25). Furthermore, ϳ15% of all human genetic diseases are believed to be caused by mutations in the splicing acceptor/donor sites, generating changes in the splicing pattern of one or more genes, which implies that alternative splicing also plays an important role in pathogenicity (19).An apparent link between certain cancer types and alternative splicing is being investigated (for a review, see Caballero et al., Ref. 8). Several splicing variants from different genes, including cd44, wt1, cd79b, bin1, and Syk, have been shown to be associated with different aspects of tumorigenesis (1, 10,13,26,32).The increasing amount of cDNA libraries constructed from a diversity of both tumor and normal tissues and cell lines allows several types of computational analyses. This, together with the release of the fina...